141083-85-4

Basic information

• Product Name: 2-Pyridinecarboxylicacid,1,2,3,6-tetrahydro-,methylester(9CI)
• Synonyms: 2-Pyridinecarboxylicacid,1,2,3,6-tetrahydro-,methylester(9CI)
• CAS NO: 141083-85-4
• Molecular Formula: C₇H₁₁NO₂
• Molecular Weight: 141.17
• Product Categories: CARBOXYLICESTER
• Mol File: 141083-85-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Pyridinecarboxylicacid,1,2,3,6-tetrahydro-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylicacid,1,2,3,6-tetrahydro-,methylester(9CI)(141083-85-4)
• EPA Substance Registry System: 2-Pyridinecarboxylicacid,1,2,3,6-tetrahydro-,methylester(9CI)(141083-85-4)

Safety Data

• Hazardous Substances Data: 141083-85-4(Hazardous Substances Data)

Upstream product

• 50299-15-5 methyl (S)-allylglycinate 
• 794514-81-1 (S)-methyl 2-(2-nitrophenylsulfonamido)pent-4-enoate 
• 282527-06-4 methyl 2-[(1-benzyloxyallyl)-(4-nitrobenzenesulfonyl)amino]-(S)-pent-4-enoate 
• 282527-08-6 methyl (2S)-6-benzyloxy-1-(4-nitrobenzenesulfonyl)-1,2,3,6-tetrahydropyridine-2-carboxylate 
• 282527-09-7 methyl (S)-1-(4-nitrobenzenesulfonyl)-1,2,3,6-tetrahydropyridine-2-carboxylate 

Downstream Products

• 145981-40-4 4,5-epoxy-2-piperidinecarboxylic acid-methyl ester 
• 144090-43-7 [(S)-1-Benzyl-2-((1S,4S,5S)-4-iodo-7-oxo-6-oxa-2-aza-bicyclo[3.2.1]oct-2-yl)-2-oxo-ethyl]-carbamic acid tert-butyl ester 
• 144090-41-5 (S)-1-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionyl)-1,2,3,6-tetrahydro-pyridine-2-carboxylic acid 
• 144090-43-7 [(R)-1-Benzyl-2-((4S,5S)-4-iodo-7-oxo-6-oxa-2-aza-bicyclo[3.2.1]oct-2-yl)-2-oxo-ethyl]-carbamic acid tert-butyl ester 
• 144090-41-5 1-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionyl)-1,2,3,6-tetrahydro-pyridine-2-carboxylic acid 
• 144090-45-9 (S)-2-((2S,3S)-2-{[(2R,4R,5R)-4-Acetoxy-1-((S)-2-tert-butoxycarbonylamino-3-phenyl-propionyl)-5-iodo-piperidine-2-carbonyl]-amino}-3-methyl-pentanoylamino)-3-methyl-butyric acid methyl ester 
• 144090-44-8 (S)-2-((2S,3S)-2-{[(2S,4S,5S)-1-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionyl)-4-hydroxy-5-iodo-piperidine-2-carbonyl]-amino}-3-methyl-pentanoylamino)-3-methyl-butyric acid methyl ester 
• 144090-44-8 (S)-2-((2S,3S)-2-{[(2R,4R,5R)-1-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionyl)-4-hydroxy-5-iodo-piperidine-2-carbonyl]-amino}-3-methyl-pentanoylamino)-3-methyl-butyric acid methyl ester 
• 144090-46-0 C₄₃H₆₆IN₇O₁₃ 
• 144090-47-1 Boc-Ser-Ala-Ala-Phe-3S-OAc-Δ-4,5-(L)-Pip-Ile-Val-OMe 
• 31456-71-0 (2S)-1,2,3,6-tetrahydropyridine-2-carboxylic acid 
• 144090-39-1 1-((S)-2-tert-Butoxycarbonylamino-3-phenyl-propionyl)-1,2,3,6-tetrahydro-pyridine-2-carboxylic acid methyl ester 

Relevant articles and documents

SELECTIVE FKBP51 LIGANDS FOR TREATMENT OF PSYCHIATRIC DISORDERS

The present invention relates to compounds of the general formula (I) having a selective FKBP51 ligand scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with

A ring-closing metathesis-mediated route to novel enantiopure conformationally restricted cyclic amino acids

A combination of palladium-catalysed N,O-acetal formation, ruthenium- catalysed ring-closing metathesis and N-sulfonyliminium ion-mediated C-C bond formation constitutes an efficient and versatile route to a set of enantiomerically pure 2,6-disubstituted unsaturated pipecolic acid derivatives.